Scroll to explore more. Hot Topics including JAK differentiation, efficacy, PROs, safety and other practicalities.
JAK INHIBITOR
Prof. Choy explains the mechanism of action of JAK Inhibitors
EFFICACY
Prof. Mysler explains how to use baricitinib for treatment in patients with RA and discusses the strong evidence for baricitinib based on Phase 3 RA-BEAM study.
PROS
Dr. Grisar explains the importance of using PROs and clinical disease activity measures in patient-centered care and discuses the effect of baricitinib on PROs.
SAFETY
Prof. Durez and Prof. Feist consider the different aspects of baricitinib's safety profile in RA that has been characterised by an extensive safety analysis.
PRACTICALITIES
Dr. Sewerin and other leading rheumatology experts address your practical concerns regarding the use of baricitinib in patients.
